new medicines
First oral COVID-19 treatments approved
Two drugs have been added to Australia’s arsenal in the fight against COVID-19, to treat people at increased risk of progression to hospitalisation or death The TGA has granted provisional …
Fast-tracking new medicines
The Commonwealth and Victorian Governments are working to establish a new National Drug Discovery Centre The move is aimed at turning ground-breaking scientific discoveries into new medicines more quickly Federal …
A new option
New fixed-dosed two-drug regimen approved for HIV—reducing patient exposure and potential drug interactions compared to usual pills containing three or more medicines The TGA has approved Dovato (dolutegravir and lamivudine), …
New cancer treatments listed on PBS
The government has announced a $48 million investment to list new treatments for lymphoma and multiple myeloma on the PBS This investment will save families up to $100,000 a year, …
Type 2 diabetes drug a ‘game changer’
A relatively new drug has been found to greatly reduce risk of cardiovascular and kidney disease – though it comes with risks of its own Canagliflozin (Invokana) is a SGLT2 …
GPs preferred over pharmacists for new medicines questions
Consumers might prefer to buy medicines in pharmacies, but they’re more likely to ask GPs about new medicines Four out of five Australians usually buy OTC and complementary medicines from …
Drug companies cause slow access to new medicines: Ley
Health Minister Sussan Ley says she wants to turn around the issue of ‘slow’ access to new medicines, which she says is caused by drug companies. Medicines manufacturers prefer to …
New leukaemia treatment from Janssen approved
A new targeted anti-cancer therapy that helps improve survival in the most common form of leukaemia, Chronic Lymphocytic Leukaemia, has received regulatory approval in Australia.
Cancer drug delays not due to PBAC processes
The Pharmaceutical Benefits Advisory Committee has spoken out against a perception that delays in access to the listing of cancer (and other) medicines are due to PBAC processes. PBAC informed …